News

ASCO GI 2026: Combining encorafenib and cetuximab with FOLFIRI may be effective first-line treatment for advanced CRC

ASCO GI 2026: ‘triple-punch’ combo therapy slows progressions of some metastatic colorectal cancers

ASCO GI 2026: Long-term study suggests walking is key to managing cancer-related fatigue

New cervical cancer screening guidelines from the US Department of Health and Human Services

ASCO GI 2026: GLP-1 receptor agonists (GLP-1s) may help reduce the risk of developing colorectal cancer

A nuclear target to revive anti-tumour immunity

Injectable breast ‘implant’ offers alternative to traditional surgeries

New prostate cancer trial seeks to reduce toxicity without sacrificing efficacy

Mathematicians tame cellular “noise” to control life at the single-cell level

Hot flush treatment has anti-breast cancer activity, study finds

Research links tumour bacteria to immunotherapy resistance in head and neck cancer

Genomic test helps flag early aggressive prostate cancer in African American patients